Dupilumab: FDA adverse event reports
479,053 FDA FAERS reports mention Dupilumab. 52,869 reports have a serious outcome flag.
Reported reactions
- Pruritus: 58,696 reports
- Dermatitis Atopic: 45,026 reports
- Product Use In Unapproved Indication: 41,226 reports
- Rash: 38,633 reports
- Injection Site Pain: 36,708 reports
- Drug Ineffective: 30,015 reports
- Eczema: 26,628 reports
- Dry Skin: 25,981 reports
- Product Dose Omission Issue: 25,295 reports
- Condition Aggravated: 20,688 reports
- Arthralgia: 19,298 reports
- Inappropriate Schedule Of Product Administration: 18,597 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.